GlassScriptPhysician profile
Clark J Tingleaf
NPI 1881624153
$456.09
in general payments reported to CMS, 2019-2025
20 companies · $70.94 in 2025
The $70.94 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $15.10 · 2021: $12.87 · 2022: $51.32 · 2023: $131 · 2024: $13.36 · 2025: $70.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $90.16 | 2022-2023 | Urolift |
| Calyxo, INC. | $30.45 | 2025 | Cvac Aspiration System |
| Avion Pharmaceuticals | $29.79 | 2019 | |
| Boston Scientific Corporation | $28.85 | 2019-2022 | |
| Therapeuticsmd, INC. | $23.82 | 2019 | |
| Lupin INC. | $23.81 | 2019 | |
| Innovation Technologies INC | $22.77 | 2025 | Irrisept |
| Gilead Sciences, INC. | $20.64 | 2019 | |
| Roche Diagnostics Corporation | $20.57 | 2019 | |
| Civco Medical Instruments | $17.72 | 2025 | |
| Alnylam Pharmaceuticals INC. | $17.24 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.46 | 2023 | Seglentis |
| Davol INC. | $15.80 | 2023 | Phasix Mesh |
| Optinose US, INC. | $15.10 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.04 | 2023 | Gattex |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.63 | 2019 | |
| Hollister Incorporated | $13.52 | 2023 | Vapro Pocket |
| Amgen INC. | $13.49 | 2019 | |
| Laborie Medical Technologies Corp. | $13.36 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Abbvie INC. | $12.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clark Tingleaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.